Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05534243 · ClinicalTrials.gov registry record · NA

The ED-AWARENESS-2 Trial

A NA study of PTSD and Mechanical Ventilation, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
3,090
Enrollment target
4
Study locations

NCT05534243 is a NA study of PTSD and Mechanical Ventilation that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 3,090 participants, above the 282-participant average among 154 other PTSD trials with a reported enrollment target (996% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05534243, a NA study of PTSD and Mechanical Ventilation, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
3,090 participants
Enrollment target
4
Study locations

Study Summary

The investigators will screen all mechanically ventilated ED patients for study eligibility and will enroll all consecutive patients satisfying inclusion and exclusion criteria. The study design is a pragmatic, multicenter, stepped wedge cluster randomized trial, enrolling at five sites over a 3-year period, divided into six time periods of six months. Prior to the study, each site will be randomized to their position within the design. One site will cross to the intervention period (i.e. succinylcholine as default neuromuscular blocker) every six months from the 2nd to 6th time period. Cluster order will be determined by computer-based randomization. To begin, each site will be exposed to control conditions; by the end of the study, each site will be exposed to intervention conditions. Patients in the control phase will receive usual care, and this phase will be entirely observational. After six months, a site will enter a 2-month transition phase. In this phase, the investigators will implement the intervention, similar to how they have implemented other ED-based interventions for mechanically ventilated patients. The investigators will engage and educate ED clinicians on the importance of AWP prevention and the study objectives. The intervention framework relies on the use of "nudges", without restricting choice. The use of neuromuscular blockers (i.e. "paralytic" medications) is already part of routine care in the ED in order to facilitate endotracheal intubation and initiation of mechanical ventilation for patients with acute respiratory failure. The two most common neuromuscular blockers used in the ED are succinylcholine and rocuronium. The preliminary data show a strong association between rocuronium (a longer-acting neuromuscular blocker) use and AWP. Therefore, this study aims to improve care by educating caregivers on AWP and the use of the neuromuscular blockers, which are already routinely used, and studying that process in a rigorous fashion. The def

Interventions

  • BEHAVIORAL Education
  • OTHER Standard neuromuscular blocker practices

Study Locations (4)

Iowa

  • Roy J. and Lucille A. Carver College of Medicine - Iowa City

Minnesota

  • Hennepin Healthcare - Minneapolis

New Jersey

  • Cooper University Hospital/Cooper Medical School of Rowan University - Camden

Washington

  • University of Washington School of Medicine - Seattle

Trial Details

FieldValue
Enrollment Target 3,090 participants
Start Date 2023-06-28
Est. Completion 2027-09-01
Phase NA

What the Registry Record Tells You About NCT05534243

The ClinicalTrials.gov registry entry for NCT05534243 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,090 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 282-participant average among 154 other PTSD trials with a reported enrollment target (996% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.

NCT05534243 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Iowa, Minnesota, New Jersey.

Frequently Asked Questions

What is clinical trial NCT05534243 about?

NCT05534243 is a clinical study titled "The ED-AWARENESS-2 Trial". The investigators will screen all mechanically ventilated ED patients for study eligibility and will enroll all consecutive patients satisfying inclusion and exclusion criteria. The study design is a pragmatic, multicenter, stepped wedge cluster randomized trial, enrolling at five sites over a 3-ye...

What is the current status of trial NCT05534243?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,090 participants. The study started on 2023-06-28. Estimated completion is 2027-09-01.

What conditions does trial NCT05534243 study?

This clinical trial studies the following conditions: PTSD, Mechanical Ventilation, Intubation Complication, Awareness.

What interventions are being tested in trial NCT05534243?

The interventions under investigation include: Education (BEHAVIORAL), Standard neuromuscular blocker practices (OTHER).

Who is sponsoring clinical trial NCT05534243?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05534243 being conducted?

This trial has 4 study locations across Iowa, Minnesota, New Jersey, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.